Consumer Court absolves Max Super Speciality Hospital, Cardio-Diabetologist of medical negligence

New Delhi: Noting that unsupported claims cannot be deemed as conclusive evidence, the Delhi State Consumer Disputes Redressal Commission has dismissed a medical negligence complaint against the Max Superspeciality Hospital, a Cardio Diabetologist, Medical Superintendent and OPD Coordinator of the hospital.

Presided over by Justice Sangita Dhingra Sehgal along with members Pinaki and JP Agrawal, the bench was deliberating a complaint, filed in 2017 that accused the hospital of deficient service and medical negligence, alleging that delays in admission and treatment led to the patient experiencing a seizure and losing consciousness in the hospital premises.

According to the complaint, the patient visited Max Super Specialty Hospital with symptoms of disorientation and loss of control of his left hand. Despite a diagnosis of bleeding inside the brain, changes in brain tissue density, and recommendations for further investigations, including MRI and Venography, the hospital staff allegedly failed to take immediate action. This purported negligence resulted in the patient suffering a seizure in the reception area, following which he was finally admitted and treated after a delay of four hours.

It was alleged that as a consequence of the delayed treatment, the patient experienced paralysis on the left side of his body and continues to suffer from seizures, requiring lifelong treatment. The complaint sought various reliefs, including a declaration of medical negligence, Rs 85 lakh compensation for loss of income, mental harassment, and legal costs.

The Opposite Parties in the case (OP1- Max Superspeciality Hospital; OP2- the doctor (M.D (Med.)) a senior consultant physician and Cardio-Diabetiologist; OP3-Medical Superintendent; OP4- OPD Coordinator) submitted a joint written statement refuting the allegations made in the Complaint. They argued that the Complainant arrived late for his appointment and was attended to after other patients. Following consultation, the Complainant’s

NCCT Scan revealed minimal traces of Subarachnoid Hemorrhage (SAH), and he was advised admission under the neurology team. The Opposite Parties asserted that all necessary medical measures were taken according to protocol and denied any medical negligence on their part.

Additionally, the hospital and the doctors claimed that the patient concealed his medical history, specifically his condition of Paraesthesia in both upper limbs, which was being evaluated and treated by the treating doctor. They argued that the SAH traces were minimal and confirmed later by tests conducted on in 2017. Consequently, they contend that the complaint is based on the suppression of material facts and should be dismissed.

In response, the Complainant filed a Rejoinder to rebut the Opposite Parties’ written statement. Both parties presented evidence through affidavits and submitted their respective written arguments to support their claims.

The State Consumer Disputes Redressal Commission heard the arguments from both sides and before discussing the case’s merits, the Commission referred to the law regarding negligence in medical professionals, citing a previous case. They outlined principles from the Kusum Sharma case, stating that negligence involves breaching a duty by omission or commission, but it must be culpable or gross, not merely based on an error of judgment. They emphasized that doctors are expected to exercise a reasonable degree of skill and care, and they can only be liable if their conduct falls below the standards of a reasonably competent practitioner. The Commission also highlighted that there can be genuine differences of opinion among medical professionals, and doctors should not be held liable for choosing one course of action over another as long as it’s acceptable to the medical profession. They underscored the importance of protecting medical professionals from unnecessary harassment and malicious proceedings while ensuring the paramount interest and welfare of patients.

In the current case, the Commission was of the view that it needs to be determined whether there was any lack of skill or competence on the part of the operating doctor, as well as any omission to perform necessary actions in the given circumstances.

It was observed that the patient had not contested the competency of the operating doctor, hence indicating no lack of competence. However, regarding the allegation of omission leading to negligence, the complainant argued that the delay in admission caused paralysis and seizures.

Upon reviewing the medical records, it was found that the doctor promptly advised necessary tests and admission upon examination. The complainant failed to provide substantial evidence supporting the claim of negligence or delay. Moreover, the choice of outpatient department (OPD) suggests minor treatment or follow-up appointments rather than immediate admission. Thus, there’s no evidence to suggest a negligent approach by the hospital staff, and allegations remain unsupported. The Commission cannot presume the allegations as true without evidence. It observed;

“…even though the Complainant has not spared a word against the operating doctor in his complaint and has challenged the delay in admitting him to the hospital, but has failed to bring on record any substantial evidence, oral or documentary, in support of his contentions. It is further noted that the Complainant failed to establish that there was any breach of duty or omission to do something which a reasonable man would do or would abstain from doing or that the treatment which was given to the Complainant was not acceptable to the Medical Profession at that specific time period and also failed to examine any Expert Witness in support of his case. Moreover, it was found that the Complainant had chosen Out-Patient Department (OPD) of Opposite Party No. 1 Hospital which is specifically designed for diagnosis, treatment, and care without requiring admission, catering to minor treatments and follow-up appointments. Additionally, in instances where patients face severe issues, they opt for the Emergency Ward, ensuring priority treatment for immediate medical attention.”

“We do not find any lackadaisical approach of the treating doctors of the Opposite Party no. 1 Hospital as no substantial evidence has been filed by the Complainant in order to show that the Opposite Parties have delayed the treatment of Complainant due to which, the Complainant has suffered seizure in reception area of the Opposite Party no. 1 Hospital. Additionally, this Commission cannot presume that the allegations in the complaint are inviolable truth even though they remained unsupported by any evidence.”

The judgment cited the Supreme Court’s ruling in C.P. Sreekumar (Dr.), MS (Ortho) v. S. Ramanujam, emphasizing the necessity for evidence to prove medical negligence. It highlights that unsupported allegations cannot be taken as evidence. The ruling read; ” We find from a reading of the order of the Commission that it proceeded on the basis that whatever had been alleged in the complaint by the respondent was in fact the inviolable truth even though it remained unsupported by any evidence. As already observed in Jacob Mathew case [(2005) 6 SCC 1: 2005 SCC (Cri) 1369] the onus to prove medical negligence lies largely on the claimant and that this onus can be discharged by leading cogent evidence. A mere averment in a complaint which is denied by the other side can, by no stretch of imagination, be said to be evidence by which the case of the complainant can be said to be proved. It is the obligation of the complainant to provide the facta probanda as well as the facta probantia.”

Since the complainant failed to provide substantiating evidence, the Commission found no negligence on the part of the hospital. Consequently, the complaint was dismissed without any cost order. The Commission held;

“Since there exists no evidence to substantiate the submission of the Complainant, we are of the view that there exists no Negligence on part of the Opposite Parties in the present case. Consequently, the present Complaint stands dismissed, with no order as to costs.”

To view the original order, click on the link below:

Powered by WPeMatico

COVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech

London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning its COVID-19 vaccine. The company has been engaged in a protracted legal dispute with its competitors over Pfizer-BioNTech’s COVID shot Comirnaty since initiating legal action in 2022, alleging copying its mRNA technology.

Pfizer and BioNTech have also countersued, alleging that Moderna’s patent is invalid.
The vaccine makers were the first to develop their COVID shots, which led to a revenue windfall during the pandemic.
Moderna said it expects its opponents to appeal the European Patent Office’s decision.
Pfizer said it was disappointed and would consider all legal options and may appeal the decision. BioNTech did not immediately respond to Reuters request for comment.
“Irrespective of the outcome of this legal matter, we will continue to manufacture and supply the Pfizer-BioNTech COVID-19 vaccine,” Pfizer said in a statement to Reuters.
The oral decision by the European Patent Office was handed down on Thursday, the Financial Times said, which was the first to report on the matter. The report added that a written decision is expected to be published in the coming months.
Pfizer, BioNTech and Moderna are also involved in parallel proceedings related to their patents in Germany, the Netherlands, Belgium, England and the United States.
Last month, a Massachusetts federal court put a patent lawsuit on hold, while the U.S. Patent Office determines whether two of the three Moderna patents at issue are valid.

Powered by WPeMatico

Delhi AIIMS leads innovative study on Ageing and longevity

New Delhi: The Department of Geriatric Medicine at the premier health institution, the All India Institute of Medical Sciences (AIIMS) Delhi has started a study unlock the secrets of a longer, healthier life.

In recent times, global conversations revolving around longevity and ageing have gained prominence as researchers worldwide aim to decipher the secrets behind a longer, healthier life.

With remarkable strides in science and technology, the exploration of the ageing process has intensified, fostering pioneering studies geared towards enhancing the well-being of individuals across generations. 

Amidst this fervent pursuit, AIIMS Delhi has emerged as a beacon of hope in the realm of ageing research. Leveraging cutting-edge technologies and a multidisciplinary approach, they have embarked on a groundbreaking study to unravel the complexities of ageing and longevity, news agency ANI reported.

Also Read:Delhi AIIMS to boost CATH Lab capacity amid growing demand

Driven by a team of dedicated scientists and healthcare professionals, the research initiative seeks to delve deeper into the mechanisms underlying ageing, with a focus on identifying key factors that influence lifespan and quality of life in later years. Through meticulous analysis of genetic, physiological, and environmental factors, researchers aim to shed light on the intricacies of the ageing process, paving the way for targeted interventions and personalized healthcare strategies.

According to a ANI report, Central to the research endeavour is the active participation of families from diverse backgrounds and age groups. The team is looking for families with members of all ages: teens (10-19), parents and middle-aged adults (40-59), grandparents (60-79), and even great-grandparents (80+).

Participants in the study will undergo a series of advanced blood-based assessments along with cognitive, functional and nutritional assessments that will help them to better understand the status of their present and future health. Rigorous measures will be implemented to ensure the privacy and confidentiality of all participants, with data handled under strict ethical guidelines and regulatory standards.

Powered by WPeMatico

Why gymgoers should be wary of using testosterone supplements to boost their gains

The desire for a sculpted physique is driving some amateur gymgoers to experiment with synthetic steroids—specifically, testosterone supplements. This trend is largely being driven by social media, with thousands of posts discussing ways to boost testosterone levels, and high-profile influencers promoting the supposed benefits of using the synthetic hormone—and even recommending products that anyone can purchase online without a prescription.

Powered by WPeMatico

If I’m diagnosed with one cancer, am I likely to get another?

Receiving a cancer diagnosis is life-changing and can cause a range of concerns about ongoing health.

Powered by WPeMatico

Unlocking the body’s defenses: Understanding immunotherapy

In the battle against diseases, the human body boasts an intricate defense network capable of identifying and neutralizing threats—the immune system. It serves as a guardian, constantly patrolling the body to keep it safe from invaders like bacteria, viruses, and even cancer cells.

Powered by WPeMatico

After 180 years, new clues are revealing just how general anesthesia works in the brain

Over 350 million surgeries are performed globally each year. For most of us, it’s likely at some point in our lives we’ll have to undergo a procedure that needs general anesthesia.

Powered by WPeMatico

Study reports ‘excellent’ outcomes for patients receiving optimized treatment for atrial fibrillation

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone. In a study published in Heart Rhythm, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation.

Powered by WPeMatico

GSK raises USD 1.5 billion from sale of remaining Haleon stake

London: British pharmaceutical company GSK has raised £1.25 billion ($1.52 billion) by selling its remaining stake in the consumer healthcare firm Haleon to institutional investors.

The sale will allow GSK to sharpen its focus on vaccines, cancer and infectious diseases, which are part of CEO Emma Walmsley’s plans to boost earnings at the drugmaker.
According to Reuters, GSK sold around 385 million shares at 324 pence each, amounting to a 4.2 per cent stake in Haleon. Friday’s sale was at a discount of about 2.5 per cent to Haleon’s last close of 332.4 pence on Thursday.
Shares in Haleon, created in a merger of GSK and Pfizer’s consumer healthcare businesses in 2019, fell as much as 1.7% in morning trade, down 0.7 per cent at 330.1 pence by 0730 GMT. 
Haleon, in which GSK initially owned nearly 13%, was spun out and listed on the London Stock Exchange in July 2022.
GSK said total proceeds from sales of its Haleon holdings – four in just over a year – stood at 3.9 billion pounds.
The company was the second-largest Haleon shareholder after Pfizer, which currently holds close to a 22.6 per cent after selling a $3.5 billion stake in March. Pfizer remains Haleon’s biggest shareholder.
Haleon, which also makes pain-killer Panadol, reported first-quarter revenue slightly below market estimates in early May on lower volumes amid retailer destocking in the U.S. and cooling demand for some of its medicines after a surge last year

Powered by WPeMatico

Tamil Nadu Health Department intensifies efforts to combat Dengue Outbreak

Chennai: The Tamil Nadu Health Department has ramped up its efforts to stem the rising cases of Dengue fever in the state, initiating measures with urgency.

With an alarming tally of over 4,000 Dengue fever cases already reported, even preceding the onset of the monsoon season, health authorities are deeply concerned. The districts of Theni, Namakkal, Tiruvannamalai, Ariyalur, Dindigul, Krishnagiri, Madurai, Coimbatore, and Thanjavur are witnessing a surge in Dengue incidences.

As per statistics, Dengue cases come down in the peak summer months of May and June while they go up in August and September when the rainy season sets in, news agency IANS reported.

Also Read:Unfortunate: PG Orthopedic Student at SSKM Hospital succumbs to dengue

The Director of Public Health and Preventive Medicine has issued comprehensive guidelines for Dengue control and prevention, urging district health officials to conduct thorough surveys for Aedes larvae and monitor vector density. These surveys will span village panchayats, town panchayats, municipalities, and corporation wards, aiming to preempt the outbreak of the disease.

According to the IANS report, The health department is also conducting mass cleaning and chlorination drives to check the breeding of the Aedes mosquitoes.

According to the health department, the state reported 136 cases of Dengue till May 16 this year. In January 2024 there was a huge spike in Dengue cases with the state reporting more than 1,200 cases. 

However, compared to 2023, the mortality rate is low this year.

Tamil Nadu reported 8,953 Dengue cases in 2023 with 10 people losing their lives to the disease. However, from 2024 till May, 4,000 cases have been reported with one death being reported in January.

Medical Dialogues team had earlier reported that the Medical Department of Rajasthan has announced their plan to utilize a mobile application for monitoring seasonal diseases, aiming for real-time surveillance. Additional Chief Secretary of the Medical and Health Department Shubhra Singh said that the online monitoring of seasonal diseases will now be done by the department through the app.

Powered by WPeMatico